AbbVie Cuts 2025 Profit Forecast on Acquisition Expenses
(Reuters) -AbbVie on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition-related expenses. The company expects adjusted profit in the range of ...
AbbVie sees FY25 adjusted EPS with expenses $11.99-$12.19, consensus $12.28
In a regulatory filing, AbbVie (ABBV) disclosed that reported GAAP earnings and adjusted non-GAAP earnings for the first quarter of 2025 are ...
Bernstein Keeps Their Hold Rating on AbbVie (ABBV)
In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on AbbVie (ABBV – Research Report), with a price target ...
Pharma Stocks Survive Market Rout on Tariff Exemption, but Uncertainty Continues
Trump imposed a 10% tariff on most U.S. imports, as well as much higher levies on dozens of rivals and allies alike, but ...
Top Landmarks Around The World To Spark The Night Blue For Parkinson's Awareness
Hull, United Kingdom 2024 New York Stock Exchange 2024 500+ sites will spark blue PD Avengers - Global Alliance to End Parkin ...